MedTrace Logo

Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts

NCT03258164 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-11-28

No results posted yet for this study

Summary

The purpose of the present study is to examine whether enrichment of a fat graft with autologous ex vivo expanded ASC injected into the breast tissue or face, both for cosmetic use, will significantly improve the results of conventional lipofilling and synthetic facial fillers, thereby being able to offer a safer, more natural and long-lasting alternative to current artificial solutions for cosmetic patients.

Conditions

  • Breast Hypoplasia and Facial Ageing

Interventions

BIOLOGICAL

ASC enriched lipofilling

Fat grafts enriched with ex vivo expanded ASC

BIOLOGICAL

Standard Lipofilling

Non-ASC enriched fat grafts

Sponsors & Collaborators

  • Aleris-Hamlet Hospitaler København

    collaborator OTHER

  • Stemform

    lead INDUSTRY

Principal Investigators

  • Stig-Frederik T Kølle, MD, PhD · Stemform

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-22
Primary Completion
2022-10-24
Completion
2022-11-22

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03258164 on ClinicalTrials.gov